These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10726349)

  • 1. [The treatment of hirsutism in adolescent girls with spironolactone].
    Malinova M
    Akush Ginekol (Sofiia); 1999; 38(4):28-30. PubMed ID: 10726349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel use of spironolactone: treatment of hirsutism.
    Shapiro G; Evron S
    J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary testosterone as an index of antiandrogen therapy in hirsutism.
    Gómez JM; Navarro MA; Arranz B; Soler J; Bonnin MR; Montaña E
    Recenti Prog Med; 1992 Dec; 83(12):672-4. PubMed ID: 1494704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hirsutism with spironolactone and with spironolactone plus dexamethasone].
    Devoto E; Aravena L; Ríos R
    Rev Med Chil; 2000 Aug; 128(8):868-75. PubMed ID: 11129548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side-effects of spironolactone therapy in the hirsute woman.
    Helfer EL; Miller JL; Rose LI
    J Clin Endocrinol Metab; 1988 Jan; 66(1):208-11. PubMed ID: 3335604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    J Clin Endocrinol Metab; 1989 May; 68(5):966-70. PubMed ID: 2715294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.
    Messina M; Manieri C; Biffignandi P; Massucchetti C; Novi RF; Molinatti GM
    J Endocrinol Invest; 1983 Feb; 6(1):23-7. PubMed ID: 6404979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.
    Vĕtr M; Sobek A
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():55-7. PubMed ID: 7976677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism.
    Akdoğan M; Tamer MN; Cüre E; Cüre MC; Köroğlu BK; Delibaş N
    Phytother Res; 2007 May; 21(5):444-7. PubMed ID: 17310494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of clinical response in hirsute women treated with spironolactone.
    Crosby PD; Rittmaster RS
    Fertil Steril; 1991 Jun; 55(6):1076-81. PubMed ID: 1828043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose spironolactone in the treatment of female hirsutism.
    Ylöstalo P; Heikkinen J; Kauppila A; Pakarinen A; Järvinen PA
    Int J Fertil; 1987; 32(1):41-5. PubMed ID: 2880814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of spironolactone on hirsutism and female androgen metabolism.
    Dorrington-Ward P; McCartney AC; Holland S; Scully J; Carter G; Alaghband-Zadeh J; Wise P
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):161-7. PubMed ID: 4053414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome.
    Evans DJ; Burke CW
    J R Soc Med; 1986 Aug; 79(8):451-3. PubMed ID: 3761287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hirsutism].
    van Zuuren EJ; Pijl H
    Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone in the treatment of hirsutism.
    Anttila L; Ruutiainen K; Erkkola R
    Ann Chir Gynaecol Suppl; 1987; 202():32-4. PubMed ID: 3310825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
    Suraci C; Costa C; De Pedrini P
    Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860
    [No Abstract]   [Full Text] [Related]  

  • 20. Spironolactone for hirsutism in polycystic ovary syndrome.
    Christy NA; Franks AS; Cross LB
    Ann Pharmacother; 2005 Sep; 39(9):1517-21. PubMed ID: 16076921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.